换一批
换一批Discovery of 6-deoxydapagliflozin as a highly potent sodium-dependent glucose cotransporter 2 (SGLT2) inhibitor for the treatment of type 2 diabetes.
第一作者：
Lingyu,Zhang
第一单位：
School of Chemistry and Chemical Engineering, Shandong University, Jinan 250100, P.R. China and Tianjin Key Laboratory of Molecular Design and Drug Discovery, Tianjin Institute of Pharmaceutical Research, 308 An Shan Xi Dao, Nankai District, Tianjin 300193, P.R. China. zhao_guilong@126.com.
作者：
主题词
动物(Animals);二苯甲基化合物(Benzhydryl Compounds);血糖(Blood Glucose);脱氧葡萄糖(Deoxyglucose);糖尿病, 实验性(Diabetes Mellitus, Experimental);糖尿病, 2型(Diabetes Mellitus, Type 2);剂量效应关系, 药物(Dose-Response Relationship, Drug);药物发现(Drug Discovery);葡糖耐量试验(Glucose Tolerance Test);人类(Humans);降血糖药(Hypoglycemic Agents);分子结构(Molecular Structure);大鼠(Rats);钠-葡萄糖转运体2(Sodium-Glucose Transporter 2);构效关系(Structure-Activity Relationship)
DOI
10.2174/15734064113096660051
PMID
24059684
发布时间
2019-12-10
- 浏览63
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
